Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05786547
PHASE3

V+PSF-M for Tobacco Cessation in HIV Care in India

Sponsor: University of Colorado, Denver

View on ClinicalTrials.gov

Summary

The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)

Official title: Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2024-01-02

Completion Date

2026-07-22

Last Updated

2025-06-15

Healthy Volunteers

No

Interventions

DRUG

Varenicline

Per package dosing, tablet taken orally

BEHAVIORAL

Positively Smoke Free Mobile (PSF-M)

Behavioral tobacco cessation intervention for people living with HIV, delivered via mobile phone

BEHAVIORAL

Standard Care

Brief cessation advice plus referral to local tobacco quitline

Locations (2)

University of Colorado

Aurora, Colorado, United States

VHS Infectious Disease Medical Centre, CART Clinical Research Site

Chennai, Tamil Nadu, India